Descriptive study of severe infections treated with phage therapy
Non Interventional Retrospective and Prospective Single Center Descriptive Study of Severe Infections Treated With Phage Therapy at the Hospices Civils de Lyon (PHAGEinLYON Clinic Cohort Study).
This study looks at how well phage therapy works for people with severe infections by gathering information from 250 patients treated at a hospital in Lyon.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Lyon) |
| Trial ID | NCT06185920 on ClinicalTrials.gov |
What this trial studies
The PHAGEinLYON Clinic cohort study is an observational study that examines patients with severe infections who have been treated with bacteriophage therapy at the Hospices Civils de Lyon from 2015 to 2033. This study includes both retrospective and prospective data collection, aiming to describe the characteristics and outcomes of these severe infections. A total of 250 patients will be enrolled to provide a comprehensive overview of the effectiveness and application of phage therapy in this context.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with severe infections who have received bacteriophage treatment at the Hospices Civils de Lyon.
Not a fit: Patients who have not been treated with bacteriophage therapy or who oppose participation in the study will not benefit.
Why it matters
Potential benefit: If successful, this study could enhance understanding of phage therapy as a treatment option for severe infections, potentially leading to improved patient outcomes.
How similar studies have performed: While phage therapy is a novel approach, there have been limited studies showing success in similar contexts, making this study particularly significant.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033 * PHAGEinLYON Clinic cohort study information notice provided to the patient Exclusion Criteria: * Opposition of trial participant
Where this trial is running
Lyon
- Department of Infectious and Tropical Diseases of the Croix Rousse Hospital of the Civil Hospitals of Lyon — Lyon, France (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.